Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study

Figure 1

Results and secondary therapies of 80 eyes of infants with retinopathy of prematurity after initial ranibizumab treatment (IVR).